Tag Archives: antiTB

New paper: Review on NSAIDS for TB

Lengthy, antimicrobial therapy targeting the pathogen is the mainstay of conventional tuberculosis treatment, complicated by emerging drug resistances. We have been working on Host-directed therapies, mainly in non-steroidal anti-inflammatory drugs (NSAIDs), since 2010.  In collaboration with our colleagues from the … Continue reading

Posted in Uncategorized | Tagged , , , , | Leave a comment

New paper

Dear all, we would like to share with you our happiness! Because our collaborators Prof. Dr. Pere Clapés and his team (Biotransformation and Bioactive Molecules Group, Catalonia Institute for Advanced Chemistry-CSIC, Barcelona) have a new manuscript accepted to be published … Continue reading

Posted in Uncategorized | Tagged , , , , , | Leave a comment